Global Marketing Director, Hemophilia Gene Therapy

ROLE SUMMARYThe Rare Disease late-stage Hemophilia Phase 3 pipeline includes 3 transformative, breakthrough medicines: BEQVEZ for Hemophilia B (Gene Therapy (GTx)), Hemophilia A GTx, and a subcutaneously delivered monoclonal antibody to treat hemophilia A & B (Marstacimab). All these products represent significant therapeutic benefits to patients offering breakthrough innovations that address today's high burden of treatment.As Pfizer is committed to bringing Breakthroughs that Change Patient's Lives, the two gene therapy programs represent an important opportunity for Pfizer to establish a new Infrastructure of Care for BEQVEZ that has implications and learnings for the Hemophilia A GTx launch. Most importantly, both gene therapies are transformative in a therapy area where the burden of disease management is substantial for patients and caregivers.Given this transformative nature of the two programs and the very competitive nature of the hemophilia marketplace, we need to prepare both the internal Pfizer and external Hemophilia community for great change. Therefore, we must build our capabilities accordingly and execute flawlessly. Success for both programs will rely on market development and launch execution, speed to market, robust clinical data and differentiation, and ability to leverage Pfizer's 25 year+ heritage of trust and leadership in hemophilia.Both gene therapies are launch assets (first approvals expected in 2024 for BEQVEZ and 2026 for Hemophilia A GTx) with accountability to contribute to near term growth and deliver on Pfizer's purpose of developing Breakthroughs that Change Patient's Lives.

This exciting and pivotal role reports to the Global Hemophilia Gene Therapy Lead and is part of the team responsible for development of key elements of the HCP and Patient global campaigns as the team prepare for the imminent launch of Pfizer's first gene-therapy. This role will work cross-functionally with the US, IDM and EM Commercial offices, CoLab and other members of the global hemophilia team which includes the global marstacimab team.

This position requires agility, proven success in establishing partnerships across multiple functions, and the ability to lead through a diverse and global set of stakeholders. The candidate should demonstrate strong leadership, communication and analytical skills, detail-oriented execution, and a proven track record of fostering cross-functional collaboration to drive a brands success, ideally through the launch phase of a brand.

ROLE RESPONSIBILITIES

Be a core member of the Hem GTx CoLab team to deliver best in class campaigns and creative materials for BEQVEZ and Pfizer's Hem A GTx asset, in line with Pfizer standards.

Develop customer insights to identify critical success factors and KPIs that inform the brands short- and long-term global HCP and Patient launch campaigns in coordination with other global marketers, the launch operations lead, and the global cross-functional team.

Ensure high level and continued collaboration with a wide range of cross-functional partners including CoLab, US, IDM and EM Commercial offices and global cross-functional leads from medical, regulatory, manufacturing, access, pricing and value to ensure successful launch practices.

Lead the tactical execution of key global marketing launch tacticsidentifiedwithin the Global operational plan.

Lead Global RC (review committee) as the Global RC captain: oversee RC discussions with. a strategic eye toward long-term implications, set and implement RC norms, tighten schedule, ensure conclusions are clearly communicated, prioritize what is going into RC when, ensure quality control, and ensure 100% commitment to compliance.

Ensure creative content is being leveraged across US, IDM and select EM geographies to maximize content reuse.

Adopt marketing tools necessary for Pfizer's ongoing digital transformation including omnichannel strategies, data-driven decision making, agile methodologies and experimentation.

Develop strong KOL relationships and be a commercial lead at external engagements including congresses.

Develop critical success factors and KPIs that inform early launch success and allow for timely adaptation as needed.

Progress strategic plans and tactics as market conditions evolve to ensure ongoing growth of the hemophilia gene therapy business.

Role model lightspeed behaviors and Pfizer values (Courage, Excellence, Equity & Joy), ensuring work is done in the right way with a compliance mindset.

Conduct all activities and make decisions that are in accordance with Company policies & SOPs, Pfizer Values & global regulatory guidelines.

QUALIFICATIONS

Minimum7+ years ofexperience in US and/or global pharmaceutical marketing

BA/BS required, MBA oradvanced degree in a related field preferred but not required.

Experience in working on launch brands within the pharmaceutical space.

Strong marketing,analytical and strategic skills including ability to identify and prioritize strategic challenges and balance short term needs with long-term vision; can manage through ambiguity.

Digital and omnichannel marketing expertise

Excellentcommunication and presentation skills

Experience collaborating withcross functional and virtualteams/colleagues

Track record of achieving results through others across functions,geographies,and a variety of personalitystyles

Ability to plan,organize, focus, and executein a fast-paced, dynamic environmentwith a high degree of urgency.

Demonstrated understanding of the operational complexities required to executeGlobal Launch readiness in a highly competitive market.

Mature, self-driven and exceptional learning agility

A commitment to excellence - both in the results achieved and in how they are achieved.

Focused on Pfizer values, demonstrates an absolute commitment to adherence to all applicable compliance rules and regulations.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

International travel based on business needs 20%

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTSInternational travel based on business needs 20%Other Job Details:Last Date to Apply for Job: February 21, 2024Work Location Assignment: On Premise NYHQ, Montreal, CA or Collegeville, PAThe annual base salary for this position ranges from $161,600.00 to $269,400.00. In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site - U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.Relocation assistance may be available based on business needs and/or eligibility.Sunshine ActPfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.EEO & Employment EligibilityPfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.Marketing and Market Research#LI-PFE